Search results

The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.

The X-ray Fluorescence Nanoprobe beamline undertakes high-resolution X-ray microspectroscopy, elemental mapping and coherent diffraction imaging – providing a unique facility capable of spectroscopic and full-field imaging. Elemental mapping and XANES studies will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using scanning X-ray diffraction microscopy.

Researchers and industry partners from UNSW Australia, the Australian Centre for Nanomedicine, Children’s Cancer Institute and Inventia Life Sciences Pty Ltd have been awarded the 2021 ANSTO Eureka Prize for Innovative Use of Technology for their method to rapidly-produce 3D cell structures

A large international collaboration has developed a straightforward and cost-effective synthesizing approach using a 3D printing technique to produce single atom catalysts (SACs)—potentially paving the way for large scale commercial production with broad industrial applications.

Detailed data on ANSTO electricity use and CO2 emissions for FY2022 - FY2023

The Australian Centre for Neutron Scattering (ACNS) is a major research facility for neutron science that comprises a suite of neutron instruments with a range of techniques for scientific investigations in physics, chemistry, materials science, medicine and environmental science among other fields.

Research highlights how biodistribution of a toxic substance essential to understand all exposure risks.